COVID-19 - what should anaethesiologists and intensivists know about it?

Anaesthesiology Intensive Therapy

Volumn 52, Issue 1, 2020, Pages 34-41

  Wujtewicz, Magdalena A ^a   Dylczyk Sommer, Anna ^a   Aszkiełowicz, Aleksander ^a   Zdanowski, Szymon ^a   Piwowarczyk, Sebastian ^a   Owczuk, Radosław ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Acute pneumonia; Acute respiratory distress syndrome (ARDS); COVID 19; Infection; SARS CoV 2; Viruses

Indexed keywords

ALPHA INTERFERON; ANGIOTENSIN CONVERTING ENZYME 2; DARUNAVIR; HYDROCORTISONE; HYDROXYCHLOROQUINE; LOPINAVIR; OXYGEN; RITONAVIR;

ADULT RESPIRATORY DISTRESS SYNDROME; ANESTHESIOLOGIST; ANESTHESIOLOGY; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BACTERIAL SUPERINFECTION; CHILL; COMPUTER ASSISTED TOMOGRAPHY; CORONAVIRUS DISEASE 2019; COUGHING; DIARRHEA; DISEASE SEVERITY; ENDOTRACHEAL INTUBATION; EXTRACORPOREAL OXYGENATION; FATIGUE; FEVER; HEALTH HAZARD; HEMOPTYSIS; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE; INTENSIVE CARE UNIT; INTENSIVIST; LABORATORY TEST; MEDICAL STAFF; MYALGIA; NEUROMUSCULAR BLOCKING; OXYGEN THERAPY; PANDEMIC; PNEUMONIA; POLYMERASE CHAIN REACTION; PRONE POSITION; RESPIRATORY CARE; RESUSCITATION; REVIEW; RHINORRHEA; SEDATION; SEPSIS; SEPTIC SHOCK; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SORE THROAT; TIDAL VOLUME; TRACHEOSTOMY; TRAVEL; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION; AGE; ATTITUDE TO HEALTH; BETACORONAVIRUS; CORONAVIRUS INFECTION; DISEASE EXACERBATION; PSYCHOLOGY; RISK FACTOR; VIRUS PNEUMONIA;

AGE FACTORS; ANESTHESIOLOGISTS; BETACORONAVIRUS; CORONAVIRUS INFECTIONS; COUGH; DISEASE PROGRESSION; FEVER; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PNEUMONIA, VIRAL; RISK FACTORS;

EID: 85082146869     PISSN: 16425758     EISSN: 17312531     Source Type: Journal    
DOI: 10.5114/AIT.2020.93756     Document Type: Review

References (41)

1. Chen L, Liu W, Zhang Q, et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect 2020; 9: 313-319. doi: 10.1080/22221751.2020.1725399.
2. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17: 181-192. doi: 10.1038/s41579-018-0118-9.
3. Wong ACP, Li X, Lau SKP, Woo PCY. Global epidemiology of bat coronaviruses. Viruses 2019; doi: 10.3390/v11020174.
4. Deng SQ, Peng HJ. Characteristics of a public health responses to the coronavirus disease 2019 outbreak in China. J Clin Med 2020; 10.3390/jcm9020575.
5. Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: a brief perspective from the front line. J Infect 2020. doi: https://doi.org/10.1016/j.jinf.2020.02.010.
6. Drosten C, Günther S, Preser W, et al. Identification of a novel coronavoirus associated with severe acute respiratory syndrome. N Eng J Med 2003; 348: 1967-1976. doi: 10.1056/NEJMoa030747.
7. WHO. Middle East respiratory system coronavirus (MERS-CoV) - The Kingdom of Saudi Arabia; 2020. Available at: https://www.who.int/csr/don/24-february-2020-mers-saudi-arabia/en/.
8. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-273. doi: 10.1038/s41586-020-2012-7.
9. Li W, Shi Z, Yu M, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005; 310: 676-679.
10. Wraap D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the perfusion conformation. Science 2020; 367: 1260-1263. doi: 10.1126/science.abb2507.
11. Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of COVID-19 based on current evidence. J Med Virol 2020. doi: 10.1002/jmv.25722.
12. Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020. doi: https://doi.org/10.1038/s41368-020-0074-x.
13. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensinconverting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 2020. doi: https://doi.org/10.1007/s00134-020-05985-9.
14. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J Virology 2020. doi: 10.1128/JVI.00127-20.
15. Tyrrell DAJ, Myint SH. Coronaviruses. In: Medical Microbiology. 4th ed. Baron S (ed.). Galveston (TX), University of Texas Medical Branch at Galveston; 1996. Chapter 60.
16. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506. doi: 10.1016/S0140-6736(20)30183-5.
17. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020. doi: https://doi.org/10.1038/s41586-020-2008-3.
18. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases. Situation update worldwide, as of 7 March 2020, 08:00.
19. Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. Med Virol 2020; 92: 441-447. doi: 10.1002/jmv.25689.
20. https://www.who.int/docs/default-source/coronaviruse/who-chinajoint-mission-on-covid-19-final-report.pdf
21. Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020. doi: 10.1001/jama.2020.3204.
22. World Health Organization (WHO). Consensus document on the epidemiology of severe acute respiratory syndrome (SARS) 2003. Geneva: WHO; 2003. Available at: http://www.who.int/csr/resources/publications/CDS_CSR_ARO_2004_2.pdf.
23. Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill 2020. doi: https://doi.org/10.2807/1560-7917.ES.2020.25.5.2000062.
24. https://www.who.int/news-room/q-a-detail/q-a-coronaviruses
25. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristic of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a desciprive study. Lancet 2020; 395: 507-513. doi: 10.1016/ S0140-6736(20)30211-7.
26. Bouadma L, Lescure F, Lucet J, Yazdanpanah Y, Timsit JF. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med 2020. doi: https://doi.org/10.1007/s00134-020-05967-x.
27. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. doi: DOI: https://doi.org/10.1515/cclm-2020-0198. Availabel at: https://www.degruyter.com/view/j/cclm.ahead-ofprint/cclm-2020-0198/cclm-2020-0198.xml#.
28. Liu J, Zheng X, Tong Q, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV and 2019-nCoV. J Med Virol 2020; doi: 10.1002/jmv.25709.
29. https://cases.rsna.org/coronavirus
30. Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019 n-CoV) infected pneumonia (standard version). Military Medical Research 2020. Available at: https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-020-0233-6.
31. Guan WJ, Ni ZY, Hu Y, et al.; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020. doi: 10.1056/NEJMoa2002032.
32. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020. doi: https://doi.org/10.1016/S2213-2600(20)30079-5.
33. Ñamendys-Silva SA. Respiratory support for patients with COVID-19 infection. Lancet 2020. doi: https://doi.org/10.1016/ S2213-2600(20)30110-7.
34. MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19. The potential role of extracorporeal membrane oxygenation. JAMA 2020. doi: 10.1001/jama.2020.2342.
35. https://emcrit.org/pulmcrit/lopinavir/
36. Zucco L, Levy N, Ketchandji D, Aziz M, Ramachandran SK. Perioperative considerations for the 2019 novel coronavirus (COVID-19); 12.02.2020; doi: https://www.apsf.org/news-updates/perioperativeconsiderations-for-the-2019-novel-coronavirus-covid-19/.
37. Rowlands J, Yeager MP, Beach M, Patel HM, Huysman BC, Loftus RW. Video observation to map hand contact and bacterial transmission in operating rooms. Am J Infect Control 2014; 42: 698-701. doi: 10.1016/j.ajic.2014.02.021.
38. Peng PWH, Ho PL, Hota SS. Outbreak of a new coronavirus: what anaesthetists should know. Br J Anaesth 2020. doi: 10.1016/j.bja. 2020.02.008.
39. Ti LK, Ang LS, Foong TW, Ng BSW. What we do when a COVID-19 patient needs an operation: operating room preparation and guidance. Can J Anaesth 2020. doi: 10.1007/s12630-020-01617-4.
40. Wong J, Goh QY, Tan Z, et al. Preparing for a COVID-19 pandemia: a review of operating room outbreak response measures in a large tertiary hospital in Singapore. Can J Anesth 2020. doi: https://doi.org/10.1007/s12630-020-01620-9.
41. Ling L, Joynt GM, Lipman J, Constantin JM, Joannes-Boyau O. COVID-19: a critical care perspective informed by lessons learnt from other viral epidemics. Anaesth Crit Care Pain Med 2020. doi: 10.1016/j.accpm.2020.02.002.